# TELA Bio, Inc.: Form DEF 14A, filed Sep 14, 2026

- Company: [TELA Bio, Inc.](/companies/tela.md) (CIK 1561921)
- Form: DEF 14A
- Filed: 2026-09-14
- Accepted by EDGAR: Sep 14, 2026, 16:05 ET
- Period: 2026-10-08
- Accession: 0001104659-26-107491
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1561921/000110465926107491/tm2624723-2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1561921/000110465926107491/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1561921/000110465926107491/tm2624723-2_def14a.htm

Filed Sep 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-107491. Last ingested by Listed: Nov 14, 2026, 23:11 ET. No prices; not investment advice.
